SCHEMBL220422

SCHEMBL220422

CC(C)N1CCC(N(CCO[Si](C)(C)C(C)(C)C)S(=O)(=O)CCNC(=O)c2ccc(Cl)s2)CC1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F10 P00742 15/20 0.56
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL221417 0.89 F10 (0.63) F10MAPK1SMN1; SMN2
SCHEMBL219860 0.85 F10 (0.65) F10MAPK1SMN1; SMN2
SCHEMBL221251 0.84 F10 (0.63) F10MAPK1SMN1; SMN2
SCHEMBL219743 0.82 F10 (0.63) F10MAPK1SMN1; SMN2
SCHEMBL222034 0.81 F10 (0.53) F10MAPK1SMN1; SMN2
SCHEMBL220224 0.81 F10 (0.57) F10
SCHEMBL219872 0.81 F10 (0.63) F10MAPK1SMN1; SMN2
SCHEMBL221616 0.80 F10 (0.60) F10MAPK1
SCHEMBL221193 0.80 F10 (0.69) F10MAPK1SMN1; SMN2
SCHEMBL219979 0.80 F10 (0.58) F10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088925-B2 low molecular weight factor Xa specific blood clotting inhibitors; less side effects; 5-Chloro-thiophene-2-carboxylic acid [2-(1-isopropyl-piperidin-4-ylsulfamoyl)-ethyl]-amide; thromboembolic diseases or restenosis; antithrombotic agents SANOFI-AVENTIS (FR) 2012-01-03 US disclosed